Navidea Biopharmaceuticals, Inc. (NAVBQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Navidea Biopharmaceuticals Max Drawdown (5Y) : 100.0% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 100.0% |
| August 31, 2026 | 100.0% |
| July 31, 2026 | 100.0% |
| June 30, 2026 | 100.0% |
| May 31, 2026 | 100.0% |
| April 30, 2026 | 100.0% |
| March 31, 2026 | 100.0% |
| February 28, 2026 | 100.0% |
| January 31, 2026 | 100.0% |
| December 31, 2025 | 100.0% |
| November 30, 2025 | 100.0% |
| October 31, 2025 | 100.0% |
| September 30, 2025 | 100.0% |
| August 31, 2025 | 100.0% |
| July 31, 2025 | 100.0% |
| June 30, 2025 | 100.0% |
| May 31, 2025 | 100.0% |
| April 30, 2025 | 100.0% |
| March 31, 2025 | 100.0% |
| February 28, 2025 | 100.0% |
| January 31, 2025 | 100.0% |
| December 31, 2024 | 100.0% |
| November 30, 2024 | 100.0% |
| October 31, 2024 | 100.0% |
| September 30, 2024 | 100.0% |
| Date | Value |
|---|---|
| August 31, 2024 | 100.0% |
| July 31, 2024 | 100.0% |
| June 30, 2024 | 100.0% |
| May 31, 2024 | 100.0% |
| April 30, 2024 | 99.36% |
| March 31, 2024 | 99.36% |
| February 29, 2024 | 99.36% |
| January 31, 2024 | 99.36% |
| December 31, 2023 | 99.36% |
| November 30, 2023 | 99.36% |
| October 31, 2023 | 99.36% |
| September 30, 2023 | 98.67% |
| August 31, 2023 | 98.67% |
| July 31, 2023 | 98.38% |
| June 30, 2023 | 98.38% |
| May 31, 2023 | 98.18% |
| April 30, 2023 | 96.42% |
| March 31, 2023 | 96.42% |
| February 28, 2023 | 96.42% |
| January 31, 2023 | 96.42% |
| December 31, 2022 | 96.42% |
| November 30, 2022 | 95.76% |
| October 31, 2022 | 95.74% |
| September 30, 2022 | 95.74% |
| August 31, 2022 | 95.74% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Windtree Therapeutics, Inc. | 100.0% |
| Biostax Corp. | 100.00% |
| GeneLink, Inc. | 99.99% |
| NovAccess Global, Inc. | 100.00% |
| Trevena, Inc. | 100.0% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -492.69 |
| Beta (5Y) | 40.29 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 101.4K% |
| Historical Sharpe Ratio (5Y) | -0.0009 |
| Historical Sortino (5Y) | -0.8053 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 99.00% |